Film and television journalist specializing in genre for Gizmodo's pop culture vertical io9. Theme park, immersive experiences and haunt insider. Geek-core lifestyle and travel writer. Featured ...

It stressed there were no issues with "clinical efficacy or safety, trial design, labelling, or manufacturing" that could suggest a lengthy delay. The EU approval is based on the results of the ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...